Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

L-Arginine and Reduced Systolic Blood Pressure

Research synthesisModerate evidenceModerate effect5 studies · 3 beneficial · 2 neutral · 0 harmful

Across 5 studies, 3 reported beneficial effects of L-arginine on systolic blood pressure, with effect sizes ranging from moderate to large (one moderate, one large, one moderate). The remaining 2 studies found neutral effects. Evidence is strongest for pregnant women and elderly populations, but results are mixed: a meta-analysis in pregnant women (2028 participants) showed a moderate reduction (MD -5.64 mmHg, very low certainty), while another systematic review in high-risk pregnancies found no statistically significant difference. One study in middle-aged/elderly individuals reported a large reduction (-10.44 mmHg) when combined with L-citrulline. Doses and durations were not consistently reported across studies.

  • Studied populations: pregnant women, elderly individuals

Caveats: Evidence is mixed: two neutral studies (one in high-risk pregnancies, one in healthy young males) suggest L-arginine may not be effective in all populations or contexts. The beneficial effect in pregnant women comes from a meta-analysis rated as very low certainty, and the largest reduction was observed with combined L-arginine and L-citrulline, not L-arginine alone. Doses and forms were largely unspecified, limiting generalizability. No publication-bias flags were triggered (beneficial proportion 60%, significant proportion 60%).

Generated Jul 13, 2026
Doses used in studies
  • g/day: 3 (median 3, IQR 33) 1 study
5 of 5 papers
Back to top